Toxicity in patients receiving adjuvant docetaxel + hormonal treatment after radical radiotherapy for intermediate or high-risk prostate cancer: a preplanned safety report of the SPCG-13 trial
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Toxicity in patients receiving adjuvant docetaxel + hormonal treatment after radical radiotherapy for intermediate or high-risk prostate cancer: a preplanned safety report of the SPCG-13 trial
Authors
Keywords
-
Journal
PROSTATE CANCER AND PROSTATIC DISEASES
Volume 15, Issue 3, Pages 303-307
Publisher
Springer Nature
Online
2012-05-01
DOI
10.1038/pcan.2012.13
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Impact of hormonal treatment duration in combination with radiotherapy for locally advanced prostate cancer: Meta-analysis of randomized trials
- (2011) Federica Cuppone et al. BMC CANCER
- Adjuvant Capecitabine, Docetaxel, Cyclophosphamide, and Epirubicin for Early Breast Cancer: Final Analysis of the Randomized FinXX Trial
- (2011) Heikki Joensuu et al. JOURNAL OF CLINICAL ONCOLOGY
- Update on radiation-based therapies for prostate cancer
- (2010) Young Kwok et al. CURRENT OPINION IN ONCOLOGY
- High-risk localized prostate cancer: role of radical prostatectomy
- (2010) Robert L Grubb et al. CURRENT OPINION IN UROLOGY
- The current status of image-guided external beam radiotherapy for prostate cancer
- (2010) Kevin L Stephans et al. CURRENT OPINION IN UROLOGY
- Trends in G-CSF use in 990 patients after EORTC and ASCO guidelines
- (2010) C. Falandry et al. EUROPEAN JOURNAL OF CANCER
- Long-Term Results of a Prospective, Phase II Study of Long-Term Androgen Ablation, Pelvic Radiotherapy, Brachytherapy Boost, and Adjuvant Docetaxel in Patients With High-Risk Prostate Cancer
- (2010) Steven J. DiBiase et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Outcomes in Localized Prostate Cancer: National Prostate Cancer Register of Sweden Follow-up Study
- (2010) P. Stattin et al. JNCI-Journal of the National Cancer Institute
- Health Related Quality of Life for Men Treated for Localized Prostate Cancer With Long-Term Followup
- (2010) George J. Huang et al. JOURNAL OF UROLOGY
- Early PSA decrease is an independent predictive factor of clinical failure and specific survival in patients with localized prostate cancer treated with radiotherapy combined or not with androgen deprivation therapy
- (2009) C. F. Heyns ANNALS OF ONCOLOGY
- Does hormone treatment added to radiotherapy improve outcome in locally advanced prostate cancer?
- (2009) Emilio Bria et al. CANCER
- Interval to Testosterone Recovery After Hormonal Therapy for Prostate Cancer and Risk of Death
- (2009) Anthony V. D'Amico et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Diabetes and Cardiovascular Disease During Androgen Deprivation Therapy: Observational Study of Veterans With Prostate Cancer
- (2009) N. L. Keating et al. JNCI-Journal of the National Cancer Institute
- Phase III Multi-Institutional Trial of Adjuvant Chemotherapy With Paclitaxel, Estramustine, and Oral Etoposide Combined With Long-Term Androgen Suppression Therapy and Radiotherapy Versus Long-Term Androgen Suppression Plus Radiotherapy Alone for High-Risk Prostate Cancer: Preliminary Toxicity Analysis of RTOG 99-02
- (2008) Seth A. Rosenthal et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Phase II Trial of Docetaxel With Rapid Androgen Cycling for Progressive Noncastrate Prostate Cancer
- (2008) Dana Rathkopf et al. JOURNAL OF CLINICAL ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started